Roche to acquire liver drug developer 89bio for up to $3.5 billion - Reuters

Reuters | Sept. 18, 2025, 9:18 a.m. | Original
Roche to acquire liver drug developer 89bio for up to $3.5 billion Reuters
US holiday shopping growth to cool this year, Mastercard forecasts - Reuters Waymo and Via to offer robotaxis for public transit, starting with Arizona - Reuters